| Project/Area Number |
24790952
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Endocrinology
|
|---|
| Research Institution | Keio University |
|---|
Principal Investigator |
KURIHARA Isao 慶應義塾大学, 医学部, 講師 (90338038)
|
|---|
| Project Period (FY) |
2012-04-01 – 2014-03-31
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2013: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2012: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
|---|
| Keywords | ミネラルコルチコイド受容体 / アルドステロン / 高血圧 / 糖尿病 / 糖鎖修飾 / O-GlcNAc修飾 |
|---|
| Research Abstract |
We showed for the first time that the mineralocorticoid receptor (MR), which is strongly associated with hypertension and cardiovascular damage, is a target for O-GlcNAc modification, one of posttranslational modifications by sugar. Our results indicate that high glucose conditions enhance O-GlcNAc modification of MR, which is associated with increased MR levels and its transcriptional activities in vitro and in vivo. Based on our results, MR is supposed to be pathologically activated even in the absence of increased circulating levels of aldosterone and the sensitivity of MR to aldosterone is upregulated in diabetes mellitus.
Our findings provide a new evidence for the efficacy of MR antagonists on resistant hypertension, nephropathy and cardiovascular diseases associated with diabetes mellitus in molecular levels.
|
